Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice.
Model: Acute lung injury induced by Escherichia coli lipopolysaccharide given intratracheally (2 mg/kg in 0.05 mL saline, pulmonary injury) or intraperitoneally (20 mg/kg in 0.5 mL saline, extrapulmonary injury), with controls receiving equivalent volumes of saline
Mesenchymal stem cells reduced lung elastance, alveolar collapse and inflammation at days 2 and 7 in both models, and reduced collagen deposition only in pulmonary acute lung injury, where matrix metalloproteinase-8 increased and tissue inhibitor of metalloproteinase-1 decreased
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.